Sociedad Española de Terapia Génica y Celular
  • Home
  • Policies & advocacy
    • Policies & advocacy
    • Regulatory information
      • GMP Guidelines
    • EMA guidance
    • ESGCT statements
    • Useful links
Home

This week in gene and cell therapy - 9 March 2018

Gene and cell therapy headlines 5 - 9 March

New xCas9 variant has higher specficity and broader PAM compatibility

Oxford based Nightstart to launch phase III clinical trial of gene therapy for choroideremia

MeirGTx recevies EMA PRIME designation for treatment of achromatopsia

AbbVie and Voyager Therapeutics to collaborate on gene therapy for Alzheimer's disease

FDA sets out path for stem cell therapies

Account login

Create a secure accountJoin
Forgotten your details?

Sponsors

Diamond

Platinum

Gold

Silver

Bronze

Copyright © 2023 Sociedad Española de Terapia Génica y Celular Member Area Terms and Conditions user account Privacy Policy Cookies Terms and Conditions membership purchase Terms and Conditions congress registration Terms and Conditions abstract submission Terms and Conditions user account RSS feed Join us Follow us